Billets de Michelle Dawson

Billet publié sur Twitter/X le 14/02/2023 14:37

Twitter/X Publication avec DOI crossref Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

1 réponse intégrée de Michelle Dawson

14/02/2023 14:48

Note: from Catherine Lord et al. 2022, the Lancet Commission report that first proposed & defined the term "profound autism": "profound autism is thus defined not by autistic features but by intellectual or language disability" https://t.co/ssQf0RByT4 so this has changed?

Voir la réponse sur Twitter/X

Liens cités structurés

2 ressources citées

Publication avec DOI Récupéré Publication crossref

Einat Waizbard‐Bartov, Deborah Fein, Catherine Lord, David G. Amaral (2023). Autism severity and its relationship to disability. Autism Research, 16(4), 685-696. Wiley.

Date de publication
14/02/2023
Identifiant
10.1002/aur.2898
Auteurs
Einat Waizbard‐Bartov, Deborah Fein, Catherine Lord, David G. Amaral
Source
Autism Research
Détails
16(4), 685-696
Type de référence
article
Éditeur
Wiley
Source de métadonnées
crossref

Résumé

Abstract Autism severity is currently defined and measured based exclusively on the severity levels of the two core symptom domains: social‐communication and restricted or repetitive patterns of behaviors and interests. Autistic individuals, however, are often diagnosed with other medical, developmental, and psychological co‐occurring conditions. These additional challenges such as intellectual disability, limited expressive and/or receptive language, and anxiety disorders, can have a tremendous impact on the day‐to‐day lives of autistic individuals, for both their adaptive functioning as well as their sense of wellbeing. Furthermore, the initial presentation of core symptoms and their likelihood of changing over time are influenced by the presence of such co‐occurring conditions. In order to truly understand how a person's autism impacts their life, both core symptoms as well as other challenges should be considered. This approach was recently taken by The Lancet Commission on the future of care and clinical research in autism, which proposed the term “profound autism” for a subgroup of individuals presenting with high core symptom severity, co‐occurring intellectual disability, and little or no language, who require extensive long‐term care. Considering other individual factors such as daily living skills, specific support needs and environmental resources would also enhance the evaluation of disability in autistic individuals. As currently employed in the assessment of intellectual disability, a multidimensional approach to autism could provide a more comprehensive system for classification of impairment. At present, however, there is no formal way to designate the combined effect of these different aspects of autism on a person's life. A comprehensive outlook that acknowledges impairments, capabilities, co‐occurring conditions, and environmental factors would be useful for identifying subgroups of individuals as well as for determining individual needs and strengths in clinical assessments.

Auteur·ices de l’étude dans cette référence citée

Publication avec DOI Récupéré Réponse intégrée crossref

Catherine Lord, Tony Charman, Alexandra Havdahl, Paul Carbone, Evdokia Anagnostou, Brian Boyd, Themba Carr, Petrus J de Vries, et al. (2022). The Lancet Commission on the future of care and clinical research in autism. The Lancet, 399(10321), 271-334. Elsevier BV.

Date de publication
janvier 2022
Identifiant
10.1016/s0140-6736(21)01541-5
Auteurs
Catherine Lord, Tony Charman, Alexandra Havdahl, Paul Carbone, Evdokia Anagnostou, Brian Boyd, Themba Carr, Petrus J de Vries, Cheryl Dissanayake, Gauri Divan, Christine M Freitag, Marina M Gotelli, Connie Kasari, Martin Knapp, Peter Mundy, Alex Plank, Lawrence Scahill, Chiara Servili, Paul Shattuck, Emily Simonoff, Alison Tepper Singer, Vicky Slonims, Paul P Wang, Maria Celica Ysrraelit, Rachel Jellett, Andrew Pickles, James Cusack, Patricia Howlin, Peter Szatmari, Alison Holbrook, Christina Toolan, James B McCauley
Source
The Lancet
Détails
399(10321), 271-334
Type de référence
article
Éditeur
Elsevier BV
Source de métadonnées
crossref

Résumé

Aucun résumé n’est disponible dans les métadonnées récupérées.

Auteur·ices de l’étude dans cette référence citée